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ABSTRACT 
Objectives 
In 2003, it was reported that motor neurone disease was linked to military service in the 
1990-91 Gulf War. A large study in the US confirmed an association with military service but 
found no association with specific conflicts or length of service. Non-veteran studies have 
suggested an association with physical activity, smoking and other risk factors.  We used 
data from the Scottish Veterans Health Study to investigate the association between motor 
neurone disease and military service in UK veterans.     
Methods 
Retrospective cohort study of 57,000 veterans born 1945-1985, and 173,000 
demographically matched civilians, using Cox proportional hazard models to compare the 
risk of motor neurone disease overall, and by sex, birth cohort, length of service and year of 
recruitment.  We had no data on smoking prevalence. 
  
Results  
Veterans had an increased risk of motor neurone disease compared with non-veterans 
(adjusted hazard ratio 1.49, 95% CI 1.01-2.21, p=0.046). The increase was independent of 
birth cohort, length or period of service, or year of recruitment. Risk was associated with a 
history of trauma or road traffic accident in both veterans and non-veterans. 
Conclusions 
We confirmed an increased risk of motor neurone disease in military veterans, although the 
absolute risk is extremely low.  We found no evidence that the increased risk was associated 
with any specific conflict. We could not rule out that smoking (and perhaps other lifestyle factors) 
may be responsible for our findings. Trauma may play a role in the increased risk but further 
studies are needed.  
 ABBREVIATIONS 
ALS – amyotrophic lateral sclerosis 
AMI - acute myocardial infarction 
CI – confidence intervals 
HR – hazard ratio 
MND – motor neurone disease 
NHS – National Health Service 
OR - odds ratio 
RR – relative risk 
RTA – road traffic accident 
SD – Standard deviation 
SES - socioeconomic status  
What this paper adds 
• US studies have shown that military service is associated with an increased risk of 
motor neurone disease, although no association with specific conflicts or length of 
service has been found. 
• This study demonstrates that UK veterans born 1945-1985 were more likely than 
non-veterans to develop motor neurone disease, although the absolute risk was 
extremely low. 
• There was no evidence of an association with specific conflicts, or with length of 
service. 
• There was an association between trauma or road traffic accident and motor 
neurone disease in both veterans and non-veterans, but the magnitude of 
association was greater in veterans. 
• Higher rates of in-service smoking, reported in earlier studies, may explain the 
difference between veterans and non-veterans. 
INTRODUCTION 
Motor neurone disease (MND), also known as amyotrophic lateral sclerosis (ALS) in the 
United States, is a rare but serious progressive degenerative neurological condition. In 
Scotland, the crude incidence is 2.25 cases per 100,000 population per year, the median 
survival time from diagnosis is 2.5 years and the 5-year survival rate is 28%.  It is more 
common in men than women.[1]  The mean age at onset varies between studies but is 
generally between 55 and 75 years; there is some evidence that the onset occurs at an 
earlier age in military personnel.[2]   
In 2003, the first report was published of an association between service in the US Armed 
Forces in the first Gulf War (1991).[3]   Case-finding by Horner et al. confirmed an increased 
risk among all deployed personnel (RR 1.92, 95% CI 1.29-2.84) and a non-significant increase 
among Reserves and the National Guard.[4]   The US Veterans Administration accepted ALS 
as a presumptive Gulf War-related illness (later extended to all active military service),[5] 
but Rose cautioned against over-interpretation of the findings of the studies,[6] whilst 
Armon noted under-ascertainment of cases in Horner et al.’s non-deployed cohort.[7] 
In 2005, an analysis of data from the American Cancer Society Cancer Prevention Study II 
(CPS II) with 3.6 million person-years of follow-up found an increased risk of ALS for any 
military service (RR 1.58, 95% CI 1.12-2.09).  The risk was elevated in every birth cohort 
examined (1915 to 1939) and was irrespective of length or period of service, which 
encompassed World Wars 1 and 2, and the Korean and Vietnam Wars.[8] The Scottish 
Veterans Health Study provided an opportunity to examine the risk of MND in a large 
population-based cohort of UK veterans spanning a broad range of military experience 
covering 1960-2012, followed up for up to 30 years, in comparison with civilians having no 
record of military service. 
 
METHODS 
The Scottish Veterans Health Study is a retrospective cohort study that comprises all 56,570 
military veterans born between 1945 and 1985 who were registered with National Health 
Service (NHS) Scotland both prior to military service and following discharge, and a 
comparison group of 172,753 individuals with no record of military service individually 
matched (3:1) by year of birth, sex and postcode sector of residence (mean population 
5,000).  The study cohort and methods have been described in detail elsewhere.[9] All 
participants were identified via their electronic NHS registration records, which provided 
demographic information, as well as the dates of entering and leaving military service for 
the veterans.  The records were linked, at the individual level, to acute and psychiatric 
hospital admissions data (Scottish Morbidity Record SMR01 and SMR 04) and death 
certificates to provide information on first episode of hospitalisation due to MND, death 
from MND and all-cause deaths. MND was defined as ICD-9 code 335.2 or ICD-10 code 
G12.2, at any position in the record.  ‘Date of diagnosis’ was defined as the date of first 
hospitalisation for MND. The veterans served between 1960 and 2012, and information was 
available for follow-up events that occurred between 1 January 1981 and 31 December 
2012 inclusive.  Socio-economic status (SES) was derived from the Scottish Index of Multiple 
Deprivation (SIMD) (http://www.scotland.gov.uk/Topics/Statistics/SIMD). No data were 
available on smoking or alcohol use. The data extract was pseudo-anonymised, and approval 
for the study was granted by the Privacy Advisory Committee of the Information Services 
Division of NHS Scotland.  As a secondary data analysis, individual consent was not required. 
 
Cox proportional hazard models were used to examine the association between veteran 
status and cumulative risk of MND, using age as the time dependent variable, age at first 
record of MND as the failure time and death (if no record of MND) as the censor time.  
Hazard ratios and p values were calculated and the a priori rejection level was set at 0.05. 
Proportionality was tested using methodology based on Schoenfeld residuals.[10] The 
models were run univariately and then repeated adjusting for the potential confounding 
effect of SES quintile.  The analyses were repeated stratifying by grouped year of birth to 
examine birth cohort effects.  Odds ratios for an association with a history of trauma 
(defined as prior hospitalisation with ICD-10 S00-S99 or T00-T32, or ICD-9 E880-E888, E890-
E929 or 800-957 in any position) or road traffic accident (RTA) (prior hospitalisation with 
ICD-10 V00-V99 or ICD-9 E810-E899 in any position), were calculated.  It was not possible to 
identify head or neck trauma as the individual V codes and E codes were not available to us.  
Mean age at MND diagnosis was calculated and case-fatality at one year and five years 
following diagnosis were compared for veterans and non-veterans.  All analyses were 
performed using Stata v12.1 (©1985-2011 StataCorp).   
RESULTS 
After data cleansing, 56,205 (99.3%) veterans and 172,741 (99.9%) non-veterans were 
included in the analysis.  There were 50,970 (90.7%) male veterans and 5,235 (9.3%) female, 
reflecting the gender balance of the Armed Forces.  The mean period of follow-up was 29.3 
years, with 6.7 million person years of follow-up among veterans and non-veterans 
combined. By the end of follow-up, 3,529 (6.3%) veterans and 14,476 (6.3%) non-veterans 
had died. During follow-up, 38 (0.07%) veterans had a record of MND compared with 78 
(0.04%) non-veterans (unadjusted HR 1.56, 95% CI 1.06-2.30, p=0.025; adjusted for SES HR 
1.49, 95% CI 1.01-2.21, p=0.046). On sub-group analysis, the difference was only significant 
among men. There was no significant difference among women, but they contributed only 
4.3% of MND cases (Table 1).   
 
Table 1. Cox proportional hazard model of the association between veteran status and risk 
of motor neurone disease  
 
   
Univariate 
 
Multivariate 
  HR 95% CI P value HR 95% CI P value 
 
Overall 
  
1.56 
 
1.06-2.30 
 
0.025 
 
1.49 
 
1.01-2.21 
 
0.046 
        
Men   1.57 1.05-2.33 0.027 1.49 1.00-2.22 0.050 
Women  1.01 0.11-9.06 0.991 1.03 0.11-9.22 0.979 
        
Birth cohort 1945-1954 1.35 0.82-2.23 0.241 1.28 0.77-2.13 0.343 
 1955-1964 2.06 1.03-4.17 0.042 1.99 0.99-4.01 0.054 
 1965-1974 2.29 0.55-9.67 0.256 2.31 0.50-9.74 0.251 
        
Case fatality 1 year 0.80 0.42-1.53 0.500 0.83 0.44-1.59 0.577 
        
 
HR hazard ratio; CI confidence interval 
 
There was no statistically significant association with any birth cohort (Table 1), period or 
length of service. 
The mean age at diagnosis in veterans was 49.7 years, SD 9.03, and was similar for non-
veterans, mean 49.7 years, SD 10.56.  Nine veterans (23.7%) and 25 non-veterans (32.1%) 
with MND were still alive at the end of the study. The mean survival from diagnosis to death 
or the end of the study was 4.4 years (SD 6.4) for veterans and 3.6 years (SD 6.4) for non-
veterans; among those who had died, the mean survival was 1.0 year (SD 1.1) for veterans 
and 2.0 years (SD 2.4) for non-veterans.   Veterans had a non-significantly lower case-fatality 
at 1 year (unadjusted HR 0.80, 95% CI 0.42-1.53, p=0.500). Adjustment for SES did not 
change the results.  
A history of trauma or road traffic accident was associated with MND in the overall cohort 
(unadjusted OR 1.51, 95% CI 1.26-1.81, p=<0.001).  Sub-group analysis showed the 
association to be statistically significant among both veterans (OR 1.71, 95% CI 1.29-2.28, 
p=0.002) and non-veterans (OR 1.43, 95% CI 1.14-1.80, p=0.006).  The odds ratio for 
developing MND, in veterans with a history of trauma or road traffic accident compared 
with non-veterans with a similar history, demonstrated that the association was stronger in 
veterans, OR 1.79, 95% CI 1.05-3.05, p=0.029.  
   
DISCUSSION 
Data from the Scottish Veterans Health Study demonstrated a statistically significant 
association between military service and MND.  The increased risk in veterans compared 
with non-veterans was seen among all birth cohorts although small numbers precluded 
statistical significance at subgroup level.  The increase only reached statistical significance 
among men, and was unrelated to period or length of service.  There was a statistically 
significant association between MND and a history of trauma or road traffic accident among 
both veterans and non-veterans. There was no evidence that veterans were younger at 
disease onset than non-veterans.   
The magnitude of association in our study (unadjusted HR 1.56) is comparable to that 
reported by Weisskopf et al. for ALS in the CPS II study (unadjusted RR 1.58).[8]  The two 
studies combined cover nearly 100 years of military service, encompassing a wide range of 
military experience and exposures. The Scottish Veterans Health Study has therefore 
corroborated existing evidence that military service increases the risk of ALS/MND, and has 
demonstrated that the increased risk is independent of exposure to conflict, length of 
service or period of service.   The Institute of Medicine of the National Academies review of 
the literature on ALS [11] suggested a number of putative risk factors; intense physical 
activity, smoking, alcohol, trauma, transmissible agents, lead, pesticides and environmental 
toxicants.  We have demonstrated an increased risk of MND in association with a history of 
trauma in our study, in both veterans and non-veterans although the association was 
stronger in the veterans.  Serving military personnel are known from other studies to have a 
higher prevalence of smoking than civilians [12], but are also generally more physically 
active, which may inter alia increase the risk of trauma; both of these factors may also help 
to explain the increased overall risk of MND observed in veterans, but would require further 
studies.  
Limitations of our study include the rarity of the condition, and the lack of data on personal 
lifestyle or occupational risk factors, or on head and neck trauma.  We were able to infer the 
likelihood of exposure to conflict from UK military history; the spread of cases throughout 
the 50-year span of service experienced by our cohort shows no relation to periods of 
operational activity.  
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